272 related articles for article (PubMed ID: 24324713)
1. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma.
Li S; Priceman SJ; Xin H; Zhang W; Deng J; Liu Y; Huang J; Zhu W; Chen M; Hu W; Deng X; Zhang J; Yu H; He G
PLoS One; 2013; 8(12):e81657. PubMed ID: 24324713
[TBL] [Abstract][Full Text] [Related]
2. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model.
Shanmugam MK; Rajendran P; Li F; Kim C; Sikka S; Siveen KS; Kumar AP; Ahn KS; Sethi G
Mol Carcinog; 2015 Oct; 54(10):971-85. PubMed ID: 24797723
[TBL] [Abstract][Full Text] [Related]
4. Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings.
Zhu Jf; Li Zj; Zhang Gs; Meng K; Kuang Wy; Li J; Zhou Xf; Li Rj; Peng Hl; Dai Cw; Shen JK; Gong Fj; Xu Yx; Liu Sf
PLoS One; 2011; 6(8):e23720. PubMed ID: 21887305
[TBL] [Abstract][Full Text] [Related]
5. Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.
Yang JG; Lu R; Ye XJ; Zhang J; Tan YQ; Zhou G
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085115
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect.
Chae IG; Song NY; Kim DH; Lee MY; Park JM; Chun KS
Food Chem Toxicol; 2020 May; 139():111253. PubMed ID: 32165235
[TBL] [Abstract][Full Text] [Related]
9. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.
Li F; Rajendran P; Sethi G
Br J Pharmacol; 2010 Oct; 161(3):541-54. PubMed ID: 20880395
[TBL] [Abstract][Full Text] [Related]
11. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis.
Yang F; Jove V; Buettner R; Xin H; Wu J; Wang Y; Nam S; Xu Y; Ara T; DeClerck YA; Seeger R; Yu H; Jove R
Cancer Biol Ther; 2012 May; 13(7):534-41. PubMed ID: 22406995
[TBL] [Abstract][Full Text] [Related]
13. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
14. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.
Xin H; Zhang C; Herrmann A; Du Y; Figlin R; Yu H
Cancer Res; 2009 Mar; 69(6):2506-13. PubMed ID: 19244102
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M
Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
[TBL] [Abstract][Full Text] [Related]
18. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Tan SM; Li F; Rajendran P; Kumar AP; Hui KM; Sethi G
J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
[TBL] [Abstract][Full Text] [Related]
19. Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling.
Lv C; Huang Y; Liu ZX; Yu D; Bai ZM
Cancer Biomark; 2016 Jun; 17(1):41-7. PubMed ID: 27314291
[TBL] [Abstract][Full Text] [Related]
20. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
